MGTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MeiraGTx Holdings PLC (MGTX) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock is currently trading at a pre-market price of $9.5, which is below analyst price targets, and has strong long-term growth potential supported by promising pipeline developments, regulatory milestones, and increased hedge fund interest. While short-term technical indicators are mixed, the long-term outlook and positive catalysts make this a solid investment opportunity.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating a positive long-term trend. However, the MACD is negatively expanding (-0.0527), and RSI (40.487) is neutral, suggesting no immediate momentum. Key support is at $9.042, with resistance at $11.41.
FDA Breakthrough Therapy Designation for AAV2-hAQP1 in xerostomia.
Hedge fund buying increased by 869.70% over the last quarter.
Analyst price targets raised by Piper Sandler ($
and RBC Capital ($24), reflecting confidence in pipeline developments and equity raise extending runway into 2028.
No recent news or congress trading data to drive immediate sentiment.
Financial performance shows a drop in net income (-138.30% YoY) and EPS (-138.00% YoY), despite revenue growth.
In 2025/Q4, revenue increased by 252.33% YoY to $75.36M, gross margin improved to 99.37% (+121.76% YoY), but net income dropped to $15.09M (-138.30% YoY) and EPS fell to $0.19 (-138.00% YoY).
Analysts maintain positive ratings with recent upgrades in price targets: Piper Sandler ($30), RBC Capital ($24), and BofA ($16). The consensus reflects confidence in the company's pipeline, regulatory milestones, and long-term growth potential.
